Acinetobacter is an opportunistic pathogen and one of the major nosocomial infections in the past 30 years. The bacteria, especially strains resistant to multiple drugs and producing ESBL, are the causative agent of serious infectious. Treatment of such infections is difficult due to their great resistance to antimicrobial drugs (
7).
The results of this study showed that four strains (13.33%) and 23 strains (76.66%) in the presence of antibiotics Kvlyntyn and Gentamycin showed the most inhibitory concentration; for the gentamicin 1024 micrograms per mL for Kvlyntyn 256 micrograms per mL.
A study in 2007 by Farahani Kheltabadi et al. (
8) on 60 species of
Acinetobacter baumannii showed that most were resistant to amikacin, tobramycin, and ceftazidime and the least were resistant to imipenem and ampicillin-sulbactam.
Wang et al. in 2003 (
9) and Smolyakov et al. in 2003 (
10) showed that most strains were sensitive to amikacin, ampicillin Sylyn-sulbactam, ceftazidime, white Pim, gentamicin, imipenem, meropenem, piperacillin-tazobactam and polymyxin B.
In Joshi et al.'s study in 2003 (
11) showed that multiple resistance to antibiotics is on the rise and resistance is up to 45% and 75%, respectively.
A large number of antibiotic resistant studies aimed at determining the sensitivity of antibiotic resistance of strains isolated from clinical samples, and in this study after the isolation of Asntv bacteria from clinical samples (urine catheter, sputum, and wound blood), antimicrobial susceptibility testing was done using a without Bayr of antibiotic, amikacin, ciprofloxacin, gentamicin, imipenem, ceftriaxone, trimethoprim, sulfamethoxazole piperacillin, and cefotaxime. The findings and conclusions of this study showed that after the isolation of 225 strains of
Acinetobacter baumannii from clinical samples, the highest sensitivity was to piperacillin, gentamicin and ciprofloxacin and most strains of
Acinetobacter baumannii were resistant to gentamicin which is probably due to indiscriminate use of these antibiotics (
12).
The study of Vafai et al. explored the antibiotic resistance of
Acinetobacter baumannii isolated from clinical settings in Tehran and the results showed that in this study, 100 isolates of
Acinetobacter baumannii and 30 isolates of
Acinetobacter baumannii and species of
Acinetobacter baumannii from patients were isolated. Most were isolated from blood samples.
Acinetobacter baumannii showed the most resistance to white Pim, ceftriaxone, amikacin, imipenem, piperacillin - tazobactam, meropenem, gentamicin, tobramycin and showed tetracycline, ampicillin sulbactam, and polymyxin B Sylyn, which were the most effective drugs. Multi-drug resistance in these strains was 70%. Of the studied isolates, ceftazidime MICs (in 84% of samples) and white imipenem (91% of sample) were equal to or more than 128 micrograms per milliliter. According to the test results, 20% of the strains had ESBL-producing enzyme (
13). In addition, studies conducted in Asia and the Middle East showed the prevalence of multidrug-resistant
Acinetobacter baumannii in these regions.
4.1. Conclusion
Considering the high rates of drug resistance in isolates from hospitals, the study recalls that in the country, large differences in the rates of resistance to different antibiotics can be seen so that environmental factors and patterns of use of antimicrobial agents must be considered. The aim of this project was to determine the prevalence of infections caused by these bacteria and their resistance to different antibiotics in different wards of hospitals in Kerman, and to investigate the prevalence of these bacteria based on a hospital. Resistant strains in different parts of the hospital were identified and the necessary steps for appropriate treatment were taken.